Thromboprophylaxis in COVID-19: Anti-FXa—the Missing Factor?

Detalles Bibliográficos
Autores principales: Dutt, Tina, Simcox, David, Downey, Colin, McLenaghan, Daniella, King, Charlotte, Gautam, Manish, Lane, Steven, Burhan, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397804/
https://www.ncbi.nlm.nih.gov/pubmed/32510975
http://dx.doi.org/10.1164/rccm.202005-1654LE
_version_ 1783565838303887360
author Dutt, Tina
Simcox, David
Downey, Colin
McLenaghan, Daniella
King, Charlotte
Gautam, Manish
Lane, Steven
Burhan, Hassan
author_facet Dutt, Tina
Simcox, David
Downey, Colin
McLenaghan, Daniella
King, Charlotte
Gautam, Manish
Lane, Steven
Burhan, Hassan
author_sort Dutt, Tina
collection PubMed
description
format Online
Article
Text
id pubmed-7397804
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Thoracic Society
record_format MEDLINE/PubMed
spelling pubmed-73978042020-08-03 Thromboprophylaxis in COVID-19: Anti-FXa—the Missing Factor? Dutt, Tina Simcox, David Downey, Colin McLenaghan, Daniella King, Charlotte Gautam, Manish Lane, Steven Burhan, Hassan Am J Respir Crit Care Med Correspondence American Thoracic Society 2020-08-01 2020-08-01 /pmc/articles/PMC7397804/ /pubmed/32510975 http://dx.doi.org/10.1164/rccm.202005-1654LE Text en Copyright © 2020 by the American Thoracic Society http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org).
spellingShingle Correspondence
Dutt, Tina
Simcox, David
Downey, Colin
McLenaghan, Daniella
King, Charlotte
Gautam, Manish
Lane, Steven
Burhan, Hassan
Thromboprophylaxis in COVID-19: Anti-FXa—the Missing Factor?
title Thromboprophylaxis in COVID-19: Anti-FXa—the Missing Factor?
title_full Thromboprophylaxis in COVID-19: Anti-FXa—the Missing Factor?
title_fullStr Thromboprophylaxis in COVID-19: Anti-FXa—the Missing Factor?
title_full_unstemmed Thromboprophylaxis in COVID-19: Anti-FXa—the Missing Factor?
title_short Thromboprophylaxis in COVID-19: Anti-FXa—the Missing Factor?
title_sort thromboprophylaxis in covid-19: anti-fxa—the missing factor?
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397804/
https://www.ncbi.nlm.nih.gov/pubmed/32510975
http://dx.doi.org/10.1164/rccm.202005-1654LE
work_keys_str_mv AT dutttina thromboprophylaxisincovid19antifxathemissingfactor
AT simcoxdavid thromboprophylaxisincovid19antifxathemissingfactor
AT downeycolin thromboprophylaxisincovid19antifxathemissingfactor
AT mclenaghandaniella thromboprophylaxisincovid19antifxathemissingfactor
AT kingcharlotte thromboprophylaxisincovid19antifxathemissingfactor
AT gautammanish thromboprophylaxisincovid19antifxathemissingfactor
AT lanesteven thromboprophylaxisincovid19antifxathemissingfactor
AT burhanhassan thromboprophylaxisincovid19antifxathemissingfactor

Ejemplares similares